AIN
AI for ENT cancers

AI for ENT cancers

location_on North Holland ,  Netherlands

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Zeno AI is the only AI solution on the market (CE-MDR approved) for the real-time detection and classification of head and neck cancers and benign lesions (starting with the throat) during routine endoscopies.

Highlights

  • First mover in the AI for ENT/Head and Neck field (CE-MDR approved)
  • Global reseller agreement with market leader in endoscopy manufacturing
  • Renowned Head and Neck clinicians as product champions
  • Clear feature expansion roadmap for bigger market share and new markets
  • Agile development team, so with 70 units sold WSK Medical is break-even

Overview

Target HK$ 27,000,000
Minimum HK$ 90,000
Investment Raised HK$ 0
Previous Rounds HK$ 2,500,000
Stage Achieving Sales
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects